2-3 December 2008
The Cumberland, London

The global pharmaceutical and life sciences industry faces significant opportunities for growth in the years ahead. The population is growing and ageing, boosting the need for medicines in both the developed and developing world. The emergence of new diseases is creating new medical needs, whilst significant changes in the way that healthcare is delivered will provide opportunities for the provision of innovative new services. In order to capitalise on these opportunities, the industry must boost the productivity of its labs through new models and approaches to R&D, leverage emerging markets for innovation, revenue growth and increasingly tailor its sales and marketing strategies to new audiences and markets.

FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.

Speakers Include:

David Brennan, CEO, AstraZeneca Plc
William Burns, Chief Executive Officer, Roche Pharmaceutical Division
Said Darwazah, Chief Executive Officer, Hikma Pharmaceuticals PLC
Wayne Gattinella, President and CEO, WebMD
Bob Go, Global Life Sciences and Health Care Industry Leader, Deloitte Touche Tohmatsu
Joseph Jimenez, Chief Executive Officer, Pharmaceuticals, Novartis International AG
Angus Russell, Chief Executive Officer, Shire Pharmaceutical Group PLC
Stefano Pessina, Executive Chairman, Alliance Boots GmBH
Jon Symonds, Managing Director, Goldman Sachs International

Conference Chair:
Andrew Jack, Pharmaceutical Correspondent, Financial Times 

As a global standard-setter, this event will once again tackle issues critical to this industry including:

• New Pricing Models for a New Era
• Tailoring Sales and Marketing Strategies to New Audiences and Markets
• Riding the Wave of Healthcare Consumerism
• Value and Performance in Pharma and Biotech - A Financial Perspective
• Harnessing the ‘Explosion of Science’ - Transforming R&D
• Leveraging Emerging Markets for Innovation and Revenue Growth

For a full agenda and to register please visit: http://www.ftpharmabiotech.com/

For registration and general enquiries, please contact Amelie Argenti:
Telephone: +44 (0)20 7775 6119 Email: amelie.argenti@ft.com